RvD1 accelerates the resolution of inflammation by promoting apoptosis of the recruited macrophages via the ALX/FasL-FasR/caspase-3 signaling pathway
Open Access
- 8 November 2021
- journal article
- research article
- Published by Springer Nature in Cell Death Discovery
- Vol. 7 (1) , 1-10
Abstract
The uncontrolled inflammatory response caused by a disorder in inflammation resolution is one of the reasons for acute respiratory distress syndrome (ARDS). The macrophage pool markedly expands when inflammatory monocytes, known as recruited macrophages, migrate from the circulation to the lung. The persistent presence of recruited macrophages leads to chronic inflammation in the resolution phase of inflammation. On the contrary, elimination of the recruited macrophages at the injury site leads to the rapid resolution of inflammation. Resolvin D1 (RvD1) is an endogenous lipid mediator derived from docosahexaenoic acid. Mice were administered RvD1 via the tail vein 3 and 4 days after stimulation with lipopolysaccharide. RvD1 reduced the levels of the inflammatory factors in the lung tissue, promoted the anti-inflammatory M2 phenotype, and enhanced the phagocytic function of recruited macrophages to alleviate acute lung injury. We also found that the number of macrophages was decreased in BAL fluid after treatment with RvD1. RvD1 increased the apoptosis of recruited macrophages partly via the FasL-FasR/caspase-3 signaling pathway, and this effect could be blocked by Boc-2, an ALX/PRP2 inhibitor. Taken together, our findings reinforce the concept of therapeutic targeting leading to the apoptosis of recruited macrophages. Thus, RvD1 may provide a new therapy for the resolution of ARDS.Keywords
This publication has 30 references indexed in Scilit:
- Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediatorsBlood, 2012
- Pulmonary Macrophage Subpopulations in the Induction and Resolution of Acute Lung InjuryAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Resolvin E1 promotes phagocytosis-induced neutrophil apoptosis and accelerates resolution of pulmonary inflammationProceedings of the National Academy of Sciences, 2012
- Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like PhenotypeThe Journal of Immunology, 2011
- Fas Determines Differential Fates of Resident and Recruited Macrophages during Resolution of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Resolvin D1 protects mice from LPS-induced acute lung injuryPulmonary Pharmacology & Therapeutics, 2011
- Resolvin D1 and Its Aspirin-triggered 17R EpimerJournal of Biological Chemistry, 2007
- Role of alveolar macrophage and migrating neutrophils in hemorrhage-induced priming for ALI subsequent to septic challengeAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Monocyte and macrophage heterogeneityNature Reviews Immunology, 2005
- Poly (ADP-ribose) polymerase, nitric oxide and cell deathTrends in Pharmacological Sciences, 1999